Continued cemiplimab with addition of chemotherapy beyond progression in patients with advanced NSCLC on 1L cemiplimab monotherapy: 5-year outcomes of EMPOWER-Lung 1

Garassino M. C., Baramidze A., Kilickap S., Sezer A., ÖZGÜROĞLU M., Gumus M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.20, no.3, 2025 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 20 Issue: 3
• Publication Date: 2025
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
• Istanbul University-Cerrahpasa Affiliated: No